|
Very interesting. I have wondered for some time why most Oncs have no interest in treating mets with simultaneous local and sytemic therapy. Eg. liver and lung mets. If the goal is to lower tumor burden, why not use every tool at their disposal? When I ask this question they always get vague and tell me "It's complicated". Maybe they're just wrong.
|